Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma

Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands
Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma ( Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands )
31 May 2025

Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery

Dr Michael Foote - Memorial Sloan Kettering Cancer Center, New York, USA
Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery ( Dr Michael Foote - Memorial Sloan Kettering Cancer Center, New York, USA )
31 May 2025

CtDNA monitoring of ER+/HER2- breast cancer during adjuvant endocrine therapy shows promise

Dr Lajos Pusztai - Yale School of Medicine, New Haven, USA
CtDNA monitoring of ER+/HER2- breast cancer during adjuvant endocrine therapy shows promise ( Dr Lajos Pusztai - Yale School of Medicine, New Haven, USA )
31 May 2025

Vepdegestrant could extend PFS for some ESR1-mutated advanced breast cancers

Dr Erika P Hamilton - Sarah Cannon Research Institute, Nashville, USA
Vepdegestrant could extend PFS for some ESR1-mutated advanced breast cancers ( Dr Erika P Hamilton - Sarah Cannon Research Institute, Nashville, USA )
31 May 2025

Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer

Dr Jean Abraham - University of Cambridge, Cambridge, UK
Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer ( Dr Jean Abraham - University of Cambridge, Cambridge, UK )
22 May 2025

Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective

Dr Ricky Frazer and Dr Sree Subramanian
Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective ( Dr Ricky Frazer and Dr Sree Subramanian )
19 May 2025

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA
WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )
7 May 2025

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA
Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )
7 May 2025

A conversational artificial intelligence system enhances precision medicine and health equity

Dr Enrique Velazquez Villarreal - City of Hope, Duarte, USA
A conversational artificial intelligence system enhances precision medicine and health equity ( Dr Enrique Velazquez Villarreal - City of Hope, Duarte, USA )
7 May 2025

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration

Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA
Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration ( Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA )
7 May 2025

Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer

Dr Chad Tang - MD Anderson Cancer Center, Houston, USA
Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer ( Dr Chad Tang - MD Anderson Cancer Center, Houston, USA )
6 May 2025

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair-deficient tumours

Dr Yelena Yuriy Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA
Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair-deficient tumours ( Dr Yelena Yuriy Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )
6 May 2025